ATRA 8-K 2026-11-10

Atara Biotherapeutics, Inc. (ATRA) 8-K dated 2026-11-10 — accession 0001104659-26-125171.

Atara Biotherapeutics, Inc. (ATRA) is a biotechnology company listed on NASDAQ.

Atara Biotherapeutics, Inc. filed a 8-K on 2026-11-10. Accession 0001104659-26-125171.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ATRA revenue for 2025-12-31 was $120.8M. Net income was $32.7M. Revenue was down 6.3% from 2024-12-31 to 2025-12-31. ATRA currently screens at market cap $87.1M.

Not investment advice. The ATRA SEC hub lists recent forms. The stock page is the research view.